Accuracy of BabySat V3 With Profound Hypoxia and Motion
1 other identifier
observational
12
1 country
1
Brief Summary
Performance testing of pulse oximeters. The protocol involves brief stable arterial oxygen desaturation in healthy volunteers and sampling arterial blood when a stable level of hypoxia has been attained and during different motion scenarios. The blood sample is analyzed for oxygen saturation with a gold standard bench CO-oximeter. This protocol is aligned with the latest ISO and FDA guidance documents for pulse oximeter testing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 14, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 15, 2022
CompletedFirst Submitted
Initial submission to the registry
October 6, 2022
CompletedFirst Posted
Study publicly available on registry
October 14, 2022
CompletedOctober 14, 2022
October 1, 2022
1 day
October 6, 2022
October 12, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluation of accuracy during motion
Determine the accuracy during varying degrees of motion and oxygen saturation
During the oxygen desaturation assessment
Interventions
Evaluation of Accuracy of BabySat V3
Eligibility Criteria
Participants in this study should be healthy, between 18 and 50 years of age and willing to participate in breathing studies with blood samples.
You may qualify if:
- The subject is male or female, aged ≥18 and \<50
- The subject is in good general health with no evidence of any medical problems
- The subject is fluent in both written and spoken English
- The subject has provided informed consent and is willing to comply with the study procedures
You may not qualify if:
- The subject is obese (BMI\>30).
- The subject has a known history of heart disease, lung disease, kidney or liver disease.
- Diagnosis of asthma, sleep apnea, or use of CPAP.
- Subject has diabetes.
- Subject has a clotting disorder.
- The subject a hemoglobinopathy or history of anemia, per subject report or the first blood sample, that in the opinion of the investigator, would make them unsuitable for study participation.
- The subject has any other serious systemic illness.
- The subject is a current smoker.
- Any injury, deformity, or abnormality at the sensor sites that in the opinion of the investigators' would interfere with the sensors working correctly.
- The subject has a history of fainting or vasovagal response.
- The subject has a history of sensitivity to local anesthesia.
- The subject has a diagnosis of Raynaud's disease.
- The subject has unacceptable collateral circulation based on exam by the investigator (Allen's test).
- The subject is pregnant, lactating or trying to get pregnant.
- The subject is unable or unwilling to provide informed consent, or is unable or unwilling to comply with study procedures.
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Owlet Baby Care, Inc.lead
- University of California, San Franciscocollaborator
Study Sites (1)
University California San Fransisco, Department of Anesthesia
San Francisco, California, 94133, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John Feiner, MD
University of California, San Francisco
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 6, 2022
First Posted
October 14, 2022
Study Start
July 14, 2022
Primary Completion
July 15, 2022
Study Completion
July 15, 2022
Last Updated
October 14, 2022
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will not share